Sorafenib for Hepatocellular Carcinoma Recurrence After Liver Transplant. Mancuso A. Transplantation 2020;104:e243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mancuso A. Sorafenib for Hepatocellular Carcinoma Recurrence After Liver Transplant. Transplantation 2020;104:e243.
PMID: 32732856